preditive factors of severe outcome in patients with covid-19 pneumonia

B. Donia (Marsa, Tunisia), M. Maalej (Marsa, Tunisia), H. Blibech (Marsa, Tunisia), H. Snene (Marsa, Tunisia), A. Jbali (Marsa, Tunisia), I. Wadhane (Marsa, Tunisia), L. Kaabi (Marsa, Tunisia), A. Laater (Marsa, Tunisia), N. Mehiri (Marsa, Tunisia), N. Ben Salah (Marsa, Tunisia), B. Louzir (Marsa, Tunisia)

Source: Virtual Congress 2021 – COVID - 19 risk predictions
Session: COVID - 19 risk predictions
Session type: E-poster
Number: 3664

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Donia (Marsa, Tunisia), M. Maalej (Marsa, Tunisia), H. Blibech (Marsa, Tunisia), H. Snene (Marsa, Tunisia), A. Jbali (Marsa, Tunisia), I. Wadhane (Marsa, Tunisia), L. Kaabi (Marsa, Tunisia), A. Laater (Marsa, Tunisia), N. Mehiri (Marsa, Tunisia), N. Ben Salah (Marsa, Tunisia), B. Louzir (Marsa, Tunisia). preditive factors of severe outcome in patients with covid-19 pneumonia. 3664

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012

Survival and predictive factors of mortality in patients with bronchiectasis
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006

Clinical features, outcome and factors associated with mortality in patients with Nocardia pneumonia
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012


The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007

Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006

Outcome predictive factors in patients with sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012


Biomarkers in severe community-acquired pneumonia (SCAP) prognosis, complications and outcomes
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012

Clinical features and prognostic factors in elderly patients with aspiration pneumonia
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012


Prediction of complications development and lethal outcome in patients with community-acquired pneumonia
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


The impact of inflammatory-response in the outcome of trauma patients with and without ventilator-associated pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 232s
Year: 2004

Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016



Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003

Proadrenomedullin (proADM) for clinical severity and prognosis in patients with pneumonia
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

Community-acquired pneumonia in COPD patients: GOLD staging is a strong predicting factor of outcome of pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

Incidence, risk factors and outcomes of nonresolving pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 991-992
Year: 2011


Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 992-993
Year: 2011